Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in Phase 2 CLOVER-WaM Study for Relapsed/Refractory Waldenstrom’s Macroglobulinemia
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reckitt Benckiser Group plc (OTC:RBGLY), UroGen Pharma Ltd. (NASDAQ:URGN), Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have…
RENO, Nev., July 07, 2025 (GLOBE NEWSWIRE) -- Monarch Casino & Resort, Inc. (NASDAQ: MCRI) announced today that it will release its 2025 second quarter financial results after the market closes on Wednesday, July 16, 2025.
Ningde, Fujian, China, July 07, 2025 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (Nasdaq: ORIS) (“Oriental Rise” or the “Company”), an integrated supplier of white- and black-tea products in mainland China, today announced that on June 30, 2025 it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is…
SAN DIEGO, July 07, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, is investigating whether BellRing Brands, Inc. (NYSE: BRBR), or any of its executive officers, violated securities laws by misrepresenting or failing to timely disclose material information to investors.
MARKHAM, Ontario, July 07, 2025 (GLOBE NEWSWIRE) -- Almost one third (32 per cent) of Canadian respondents to a survey that say they are active on social media post about their plans before or while traveling, a figure that rises to 51 per cent among those aged 18 to 34. Posting that beach vacation selfie…
Tue, 29 Apr 2025 16:59:00 GMT FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the dis ...
Sun, 12 Jan 2025 15:00:00 GMT Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference Jan. 12, 2025 6:00 PM ET Cellectar Biosciences, Inc. (CLRB) ...
Sun, 12 Jan 2025 15:00:00 GMT Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in Phase 2 CLOVER-WaM Study for Relapsed/Refractory ...
Sun, 12 Jan 2025 10:00:00 GMT --Cellectar Biosciences, Inc., a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announces ...
Sun, 12 Jan 2025 10:00:00 GMT FLORHAM PARK, N.J., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and ...
